Insights

Innovation and advanced solutions for the pharmaceutical market.

Here are the main trends that cannot be ignored when approaching the Japanese pharmaceutical market.

With IBSA, science, advanced technology, research, and a patient-centered approach will once again take center stage at CPhI Japan from April 9-11, 2025.

Andrea Toborelli (Business Development and Licensing Manager), Shawn Valenti (Business Development Manager) and Beatrice Pisano (Senior Business Development Communication Specialist) at IBSA were interview by Chimica Oggi – Chemistry Today.

Osteoarthritis, the most common cause of musculoskeletal disability. Let’s find out more with the IBSA NAHYCO® HYBRID TECHNOLOGY.

As a global pharmaceutical company, IBSA is driven by a distinct vision of care, which starts at the Swiss headquarters and extends globally through continued growth in Europe, Asia, and North America. IBSA’s technologies are aimed at creating more advanced treatment systems to provide healthcare professionals with innovative, effective and reliable therapeutic solutions that improve patients’ quality of life. The product portfolio<div class="h10"></div><a class="more-link1" href="https://www.businessdevelopment.ibsagroup.com/news-eventi/cphi-october-24-26-barcelona-ibsa-presents-cutting-edge-technologies-to-drive-pharmaceutical-innovation/">Read more</a>

Andrea Toborelli, Business Development and Licensing Manager at IBSA, was interview by Nutra Horizons. 

As a global pharmaceutical company, IBSA is driven by a distinct vision of care, which starts at the Swiss headquarters and extends globally through continued growth in Europe, Asia, and North America. IBSA’s technologies are aimed at creating more advanced treatment systems to provide healthcare professionals with innovative, effective and reliable therapeutic solutions that improve patients’ quality of life. The product portfolio<div class="h10"></div><a class="more-link1" href="https://www.businessdevelopment.ibsagroup.com/news-eventi/cphi-october-24-26-barcelona-ibsa-presents-cutting-edge-technologies-to-drive-pharmaceutical-innovation-2/">Read more</a>